1. Home
  2. AOSL vs IOVA Comparison

AOSL vs IOVA Comparison

Compare AOSL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha and Omega Semiconductor Limited

AOSL

Alpha and Omega Semiconductor Limited

HOLD

Current Price

$22.57

Market Cap

940.9M

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.33

Market Cap

881.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOSL
IOVA
Founded
2000
2007
Country
United States
United States
Employees
N/A
838
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
940.9M
881.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AOSL
IOVA
Price
$22.57
$2.33
Analyst Decision
Buy
Buy
Analyst Count
3
12
Target Price
$24.33
$10.45
AVG Volume (30 Days)
308.9K
12.5M
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$696,776,000.00
$250,425,000.00
Revenue This Year
N/A
$60.71
Revenue Next Year
$6.59
$59.52
P/E Ratio
N/A
N/A
Revenue Growth
5.81
175.62
52 Week Low
$15.90
$1.64
52 Week High
$46.65
$6.50

Technical Indicators

Market Signals
Indicator
AOSL
IOVA
Relative Strength Index (RSI) 61.53 45.76
Support Level $21.86 $2.21
Resistance Level $22.56 $2.80
Average True Range (ATR) 0.70 0.18
MACD 0.22 -0.05
Stochastic Oscillator 77.84 20.74

Price Performance

Historical Comparison
AOSL
IOVA

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: